دورية أكاديمية

A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines.

التفاصيل البيبلوغرافية
العنوان: A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines.
المؤلفون: Lee J; Department of Biochemistry, University of Washington, Seattle, Washington, USA., Stewart C; Department of Biochemistry, University of Washington, Seattle, Washington, USA., Schäfer A; Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA., Leaf EM; Department of Biochemistry, University of Washington, Seattle, Washington, USA.; Institute for Protein Design, University of Washington, Seattle, WA, USA., Park YJ; Department of Biochemistry, University of Washington, Seattle, Washington, USA.; Howard Hughes Medical Institute, Seattle, WA, USA., Asarnow D; Department of Biochemistry, University of Washington, Seattle, Washington, USA., Powers JM; Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA., Treichel C; Department of Biochemistry, University of Washington, Seattle, Washington, USA.; Institute for Protein Design, University of Washington, Seattle, WA, USA., Sprouse KR; Department of Biochemistry, University of Washington, Seattle, Washington, USA.; Howard Hughes Medical Institute, Seattle, WA, USA., Corti D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Baric R; Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA., King NP; Department of Biochemistry, University of Washington, Seattle, Washington, USA.; Institute for Protein Design, University of Washington, Seattle, WA, USA., Veesler D; Department of Biochemistry, University of Washington, Seattle, Washington, USA. dveesler@uw.edu.; Howard Hughes Medical Institute, Seattle, WA, USA. dveesler@uw.edu.
المصدر: Nature communications [Nat Commun] 2024 Jun 28; Vol. 15 (1), pp. 5496. Date of Electronic Publication: 2024 Jun 28.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [London] : Nature Pub. Group
مواضيع طبية MeSH: Antibodies, Neutralizing*/immunology , Antibodies, Viral*/immunology , Spike Glycoprotein, Coronavirus*/immunology , SARS-CoV-2*/immunology , COVID-19*/prevention & control , COVID-19*/immunology , COVID-19*/virology, Animals ; Mice ; Humans ; Female ; COVID-19 Vaccines/immunology ; COVID-19 Vaccines/administration & dosage ; Mice, Inbred BALB C
مستخلص: Evolution of SARS-CoV-2 alters the antigenicity of the immunodominant spike (S) receptor-binding domain and N-terminal domain, undermining the efficacy of vaccines and antibody therapies. To overcome this challenge, we set out to develop a vaccine focusing antibody responses on the highly conserved but metastable S 2 subunit, which folds as a spring-loaded fusion machinery. We describe a strategy for prefusion-stabilization and high yield recombinant production of SARS-CoV-2 S 2 trimers with native structure and antigenicity. We demonstrate that our design strategy is broadly generalizable to sarbecoviruses, as exemplified with the SARS-CoV-1 (clade 1a) and PRD-0038 (clade 3) S 2 subunits. Immunization of mice with a prefusion-stabilized SARS-CoV-2 S 2 trimer elicits broadly reactive sarbecovirus antibodies and neutralizing antibody titers of comparable magnitude against Wuhan-Hu-1 and the immune evasive XBB.1.5 variant. Vaccinated mice were protected from weight loss and disease upon challenge with XBB.1.5, providing proof-of-principle for fusion machinery sarbecovirus vaccines.
(© 2024. The Author(s).)
التعليقات: Update of: bioRxiv. 2023 Dec 20:2023.12.12.571160. doi: 10.1101/2023.12.12.571160. (PMID: 38168207)
References: Science. 2021 Aug 6;373(6555):648-654. (PMID: 34210893)
Nat Struct Mol Biol. 2015 Nov;22(11):833-4. (PMID: 26581513)
Nat Struct Mol Biol. 2019 Jun;26(6):481-489. (PMID: 31160783)
Science. 2021 Sep 03;373(6559):1109-1116. (PMID: 34344823)
Sci Transl Med. 2021 Jun 30;13(600):. (PMID: 34103407)
N Engl J Med. 2022 Oct 6;387(14):1279-1291. (PMID: 36112399)
Nature. 2022 Feb;602(7896):300-306. (PMID: 34823256)
Protein Eng. 1998 Apr;11(4):329-32. (PMID: 9680195)
Science. 2022 Aug 12;377(6607):735-742. (PMID: 35857703)
Science. 2020 Mar 13;367(6483):1260-1263. (PMID: 32075877)
Science. 2022 Jan 28;375(6579):449-454. (PMID: 34990214)
Nature. 2023 Feb;614(7948):521-529. (PMID: 36535326)
Nat Methods. 2019 Nov;16(11):1153-1160. (PMID: 31591578)
Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):E7348-E7357. (PMID: 28807998)
Cell. 2020 Nov 12;183(4):1070-1085.e12. (PMID: 33031744)
Structure. 2019 Jan 2;27(1):134-139.e3. (PMID: 30344107)
Cell. 2020 Nov 25;183(5):1367-1382.e17. (PMID: 33160446)
Nature. 2022 Feb;602(7898):664-670. (PMID: 35016195)
J Comput Chem. 2004 Oct;25(13):1605-12. (PMID: 15264254)
Nature. 2020 Oct;586(7830):567-571. (PMID: 32756549)
Science. 2022 Nov 25;378(6622):eabo2523. (PMID: 36302057)
Sci Immunol. 2022 Oct 28;7(76):eadd4853. (PMID: 35857583)
Nat Methods. 2017 Mar;14(3):290-296. (PMID: 28165473)
Elife. 2016 Sep 26;5:. (PMID: 27669148)
Nature. 2023 Sep;621(7979):592-601. (PMID: 37648855)
Sci Transl Med. 2022 Mar 23;14(637):eabi9215. (PMID: 35133175)
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21. (PMID: 20057044)
Nat Methods. 2022 Jun;19(6):679-682. (PMID: 35637307)
J Mol Biol. 2012 Jan 13;415(2):406-18. (PMID: 22100448)
Cell. 2020 Apr 16;181(2):281-292.e6. (PMID: 32155444)
Science. 2022 Nov 11;378(6620):619-627. (PMID: 36264829)
Cell Rep. 2022 Dec 20;41(12):111845. (PMID: 36493787)
Nature. 2021 Jun;594(7862):253-258. (PMID: 33873199)
Science. 2020 Sep 18;369(6510):1501-1505. (PMID: 32703906)
IUCrJ. 2019 Jan 01;6(Pt 1):5-17. (PMID: 30713699)
Nat Med. 2023 Jan;29(1):247-257. (PMID: 36265510)
J Mol Biol. 2003 Oct 31;333(4):721-45. (PMID: 14568533)
Cell Rep. 2023 Apr 25;42(4):112326. (PMID: 37000623)
Nat Med. 2021 Dec;27(12):2108-2110. (PMID: 34728830)
Science. 2021 Dec 24;374(6575):1621-1626. (PMID: 34751595)
Nature. 2021 Aug;596(7873):583-589. (PMID: 34265844)
Nat Commun. 2023 Apr 10;14(1):2003. (PMID: 37037866)
Nat Commun. 2021 Mar 17;12(1):1715. (PMID: 33731724)
Cell. 2022 Mar 3;185(5):872-880.e3. (PMID: 35123650)
Science. 2022 Aug 12;377(6607):728-735. (PMID: 35857439)
Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11157-11162. (PMID: 29073020)
Nature. 2016 Mar 3;531(7592):114-117. (PMID: 26855426)
Elife. 2023 Mar 21;12:. (PMID: 36942851)
Ultramicroscopy. 2013 Dec;135:24-35. (PMID: 23872039)
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501. (PMID: 20383002)
Science. 2020 Nov 20;370(6519):950-957. (PMID: 32972994)
Immunity. 2023 Mar 14;56(3):669-686.e7. (PMID: 36889306)
Cell Rep. 2022 May 17;39(7):110829. (PMID: 35550680)
Nat Struct Mol Biol. 2021 Jun;28(6):478-486. (PMID: 33981021)
Nature. 2022 Feb;602(7898):657-663. (PMID: 35016194)
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877. (PMID: 31588918)
Nature. 2024 Jan;625(7993):148-156. (PMID: 37993710)
Sci Immunol. 2022 Dec 23;7(78):eadf1421. (PMID: 36356052)
Cell Host Microbe. 2023 Dec 13;31(12):1961-1973.e11. (PMID: 37989312)
Proc Natl Acad Sci U S A. 2023 Dec 5;120(49):e2314392120. (PMID: 38011546)
Cell Rep. 2021 Nov 2;37(5):109929. (PMID: 34710354)
EClinicalMedicine. 2022 Jul 22;51:101569. (PMID: 35879941)
Elife. 2018 Nov 09;7:. (PMID: 30412051)
Nat Commun. 2017 Apr 10;8:15092. (PMID: 28393837)
Nat Methods. 2020 Dec;17(12):1214-1221. (PMID: 33257830)
Nat Microbiol. 2022 Jul;7(7):1063-1074. (PMID: 35773398)
J Struct Biol. 2005 Jul;151(1):41-60. (PMID: 15890530)
Sci Immunol. 2021 Dec 10;6(66):eabj5129. (PMID: 34890255)
Cell. 2020 Nov 12;183(4):1024-1042.e21. (PMID: 32991844)
Nat Methods. 2019 Nov;16(11):1146-1152. (PMID: 31591575)
Science. 2022 Feb 25;375(6583):864-868. (PMID: 35076256)
Nature. 2021 Nov;599(7883):114-119. (PMID: 34488225)
Nat Commun. 2021 Jan 14;12(1):372. (PMID: 33446655)
Protein Sci. 2017 Jan;26(1):113-121. (PMID: 27667334)
Protein Sci. 2018 Jan;27(1):14-25. (PMID: 28710774)
Cell. 2019 Feb 21;176(5):1026-1039.e15. (PMID: 30712865)
Sci Rep. 2018 Oct 24;8(1):15701. (PMID: 30356097)
N Engl J Med. 2020 Dec 17;383(25):2439-2450. (PMID: 33053279)
Cell. 2021 Apr 29;184(9):2332-2347.e16. (PMID: 33761326)
J Struct Biol. 2012 Dec;180(3):519-30. (PMID: 23000701)
معلومات مُعتمدة: 75N93022C00036 United States AI NIAID NIH HHS; DP1 AI158186 United States AI NIAID NIH HHS; P01 AI167966 United States AI NIAID NIH HHS
المشرفين على المادة: 0 (Antibodies, Neutralizing)
0 (Antibodies, Viral)
0 (Spike Glycoprotein, Coronavirus)
0 (COVID-19 Vaccines)
0 (spike protein, SARS-CoV-2)
تواريخ الأحداث: Date Created: 20240629 Date Completed: 20240629 Latest Revision: 20240708
رمز التحديث: 20240708
مُعرف محوري في PubMed: PMC11214633
DOI: 10.1038/s41467-024-49656-5
PMID: 38944664
قاعدة البيانات: MEDLINE
الوصف
تدمد:2041-1723
DOI:10.1038/s41467-024-49656-5